NCT Number: NCT00182104
International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures
Compare heparin/warfarin to ASA for thromboembolic prophylaxis in the first two years following Fontan procedures.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Royal Children's Hospital, Parkville, Victoria, Australia
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient is scheduled to have a Fontan or modified Fontan procedure
Exclusion criteria
- Requirement for long-term anticoagulation (e.g., prosthetic heart valve, active DVT)
- Risk of significant bleeding or any other known medical contraindication to Heparin, Warfarin, or ASA.
- Inability to supervise therapy due to social or geographical reasons.
- Pregnancy or potential pregnancy during study period
Treatment and study plan
Primary outcomes
-
Warfarin vs ASA in prevention of thrombosis 2 yrs after Fontan
Secondary outcomes
-
Identify subpopulation of Fontan pts at high risk for TEs
-
Determine high risk period for TEs in first 2 yrs post Fontan
Sponsors and collaborators
Lead sponsor
Hamilton Health Sciences Corporation
Other
Collaborators
- Heart and Stroke Foundation of Canada
Registry information
Official study title
An International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures
Important dates
- Study start
- 1998
- Study completion
- 2005
- First posted
- Sep 16, 2005
- Registry last updated
- Apr 20, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
NCT06062329
Acute Pulmonary Embolism, Cardiovascular Diseases
Huntsville, Alabama, United States
View Trial DetailsECMO Hemostatic Transfusions in Children
NCT05796557
Cardiovascular Diseases, Embolism and Thrombosis
Atlanta, Georgia, United States
View Trial DetailsPharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
NCT02846532
Cardiovascular Diseases, Embolism and Thrombosis
Los Angeles, California, United States
View Trial DetailsApixaban for the Acute Treatment of Venous Thromboembolism in Children
NCT02464969
Cardiovascular Diseases, Embolism
Birmingham, Alabama, United States
View Trial Details